Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 31;40 Suppl 1(Suppl 1):A67-A76.
doi: 10.1016/j.vaccine.2022.01.024. Epub 2022 Feb 15.

Cost of human papillomavirus vaccine delivery at district and health facility levels in Zimbabwe: A school-based vaccination program targeting multiple cohorts

Affiliations

Cost of human papillomavirus vaccine delivery at district and health facility levels in Zimbabwe: A school-based vaccination program targeting multiple cohorts

Anna Hidle et al. Vaccine. .

Abstract

Background: After a pilot project in 2014-15 Zimbabwe introduced the human papillomavirus (HPV) vaccine nationally in 2018 for girls aged 10-14 years through a primarily school-based vaccination campaign with two doses administered at 12-month intervals. In 2019, a first dose was delivered to a new cohort of girls in grade 5 of girls age 10 years if out-of-school (OOS), along with a second dose to the 2018 multiple cohorts. Additional effort was made to identify and mobilize OOS girls by Village Health Workers (VHWs) in the community. Zimbabwe reported 1,569,905 doses of HPV vaccine administered during the 2018 and 2019 campaigns. This analysis evaluated the cost of Zimbabwe's national HPV vaccine introduction.

Methods: A retrospective, incremental, ingredients-based cost analysis from the provider perspective was conducted in 2018 and 2019. Financial and economic cost data were collected at district and health facility levels using a two-stage cluster sampling approach and four cost dimensions: program activity, resource input, payer, and administrative level. Costs are presented in 2020 US$ in total and per dose.

Results: The total weighted costs for combined district and health facility administrative levels were US$ 828,731 (financial) and US$ 2,060,943 (economic). For service delivery, the total weighted cost per dose was US$ 0.16 (financial) and US$ 0.59 (economic). The program activities with the largest share of total weighted financial cost were training (37% of total) and service delivery (30%), while the largest shares of total weighted economic costs were service delivery (45%) and training (19%). Efforts by VHWs to reach OOS girls resulted in an additional US$ 2.99 in financial cost per dose and US$ 7.79 in economic cost per dose.

Conclusion: The service delivery cost per dose was lower than that documented in the pilot program cost analysis in Zimbabwe and studies elsewhere, reflecting a campaign delivery approach that spread fixed costs over a large vaccination cohort. The additional cost of reaching OOS girls with the HPV vaccine was documented for the first time in low- and middle-income countries, which may provide information on potential costs for other countries.

Keywords: Cost; Cost analysis; Human papillomavirus; Vaccine introduction; Zimbabwe.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1.
Fig. 1.
Diagram of cost dimensions for a nationwide HPV vaccination program in Zimbabwe.
Fig. 2.
Fig. 2.
District Unweighted financial cost distribution (2020 US$) (January 2018–June 2019).
Fig. 3.
Fig. 3.
Health Facility Unweighted Financial Cost Distribution (2020 US$) (January 2018–June 2019).
Fig. 4.
Fig. 4.
Additional Weighted Cost to reaching Out-of-School girls per dose (2020 US$) (January 2018–June 2019) *. *Estimated number of doses delivered to out-of school girls = 26,350.

References

    1. International Agency for Research on Cancer. Cervix uteri cancer fact sheet [Internet]. Global Cancer Observatory; 2020. [cited 2021 FEB 08]. Available from: 23-Cervix-uteri-fact-sheet.pdf (iarc.fr).
    1. World Health Organization. Human papillomavirus vaccines: WHO position paper, May 2017. (Weekly Epidemiologic Record; ). Report No.: 92(19):241–268.
    1. Meeting of the Strategic Advisory Group of Experts on immunization. October 2016 - conclusions and recommendations [Internet]. World Health Organization; 2016. Dec p. 561–84. (Weekly Epidemiologic Record). Report No.: 48, 91. Available from: http://apps.who.int/iris/bitstream/10665/251810/1/WER9148.pdf?ua=1.
    1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136(5):E359–86. - PubMed
    1. Bruni L, Barrionuevo-Rosas L, Serrano B, et al. Human papillomavirus and related diseases report in Zimbabwe [Internet]; 2014. [cited 2021 FEB 08]. (ICO Information Centre on HPV and Cancer; ). Available from: http://www.hpvcentre.net/statistics/reports/ZWE.pdf.

Substances